Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | GSTP1 | P09211 | 2/20 | 0.34 |
| ▸ | GLB1 | P16278 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.32 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5846547 | 1.00 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AIDO1GSTP1 | |
| SCHEMBL6839631 | 1.00 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AIDO1GSTP1 | |
| SCHEMBL14929223 | 1.00 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AIDO1GSTP1 | |
| SCHEMBL18568726 | 1.00 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AIDO1GSTP1 | |
| SCHEMBL10158814 | 1.00 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AIDO1GSTP1 | |
| SCHEMBL24371821 | 1.00 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AIDO1GSTP1 | |
| SCHEMBL2308101 | 1.00 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AIDO1GSTP1 | |
| SCHEMBL1096325 | 1.00 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AIDO1GSTP1 | |
| SCHEMBL10158905 | 0.94 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2AIDO1GSTP1 | |
| SCHEMBL10158790 | 0.94 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2AIDO1GSTP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6316581-B1 | FOR IMPLANTABLE TIME-RELEASE DEVICE, ENCAPSULATION DEVICE | GROSS RICHARD A (US) | 2001-11-13 | — | — | US | claimed |
| US-20210379253-A1 | IMMOBILISED BIOLOGICAL ENTITIES | CARMEDA AB (SE) | 2021-12-09 | — | — | US | disclosed |
| US-20210308283-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | MODERNA THERAPEUTICS, INC. | 2021-10-07 | — | — | US | disclosed |
| WO-2020070258-A1 | IMMOBILISED BIOLOGICAL ENTITIES | CARMEDA AB (SE) | 2020-04-09 | — | — | WO | disclosed |
| WO-2018035050-A1 | PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY | OPKO PHARMACEUTICALS, LLC (US) | 2018-02-22 | — | — | WO | disclosed |
| US-6316581-B1 | FOR IMPLANTABLE TIME-RELEASE DEVICE, ENCAPSULATION DEVICE | GROSS RICHARD A (US) | 2001-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210308283-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | ADAR, NT5C3B, NSUN2 | ALDH1A1 2620/4885MEN1 2176/4885KMT2A 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.